Success Stories: EB1A Approval for a Postdoctoral Fellow in the field of Molecular Oncology in only 3 days
Client’s Testimonial:
[Chen Immigration Law Associates] was very knowledgeable, efficient and responsive throughout the entire process. I would highly recommend her.
On September 12th, 2013 we received another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Fellow in the field of Molecular Oncology (Approval Notice)
General Field: Molecular Oncology Position at the Time of Case Filing: Postdoctoral Fellow National Origin: India Service Center: Texas Service Center (TSC) State of Residence at the Time of Filing: Texas Approval Notice Date: September 12, 2013 Processing Time: 3 days (Premium Processing Service requested)
Case Summary:
The client in this case was a postdoctoral fellow from India in the field of molecular oncology. His work had resulted in at least 9 peer-reviewed scientific articles and 11 conference proceedings. At the time that his case was filed, his publications had accumulated at least 321 citations, clearly demonstrating that he had influenced his field and garnered international acclaim. In addition, he had reviewed 19 manuscripts for 9 journals related to the field of molecular oncology. We also presented evidence that our client and his research had appeared in a number of articles in major and professional trade publications. Of his accomplishments, one of his independent recommenders remarked, “[Client] has focused on cancer research and has made many significant discoveries in the field of both skin and prostate cancer, with many implications to other cancer types as well. His work has been remarkably beneficial to the field of cancer research worldwide, as he has the unique dual abilities of delineating alterations in pathways that make them cancerous in addition to formulating potential treatments to deter them.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of molecular oncology, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in just 3 days.

